Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA T-Cell therapy Market, by End User
1.4.2 LAMEA T-Cell therapy Market, by Indication
1.4.3 LAMEA T-Cell therapy Market, by Therapy Type
1.4.4 LAMEA T-Cell therapy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Trials and Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Sep – 2023, May) Leading Players
Chapter 4. LAMEA T-Cell therapy Market by End User
4.1 LAMEA Hospitals Market by Country
4.2 LAMEA Cancer Treatment Centers Market by Country
Chapter 5. LAMEA T-Cell therapy Market by Indication
5.1 LAMEA Lymphoma Market by Country
5.2 LAMEA Acute Lymphocytic Leukemia Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA T-Cell therapy Market by Therapy Type
6.1 LAMEA CAR T-Cell Therapy Market by Country
6.2 LAMEA T-Cell therapy Market by CAR T-Cell Therapy Type
6.2.1 LAMEA Axicabtagene Ciloleucel Market by Country
6.2.2 LAMEA Tisagenlecleucel Market by Country
6.2.3 LAMEA Brexucabtagene Autoleucel Market by Country
6.2.4 LAMEA Others Market by Country
6.3 LAMEA T-Cell Receptor (TCR)-Based Market by Country
Chapter 7. LAMEA T-Cell therapy Market by Country
7.1 Brazil T-Cell therapy Market
7.1.1 Brazil T-Cell therapy Market by End User
7.1.2 Brazil T-Cell therapy Market by Indication
7.1.3 Brazil T-Cell therapy Market by Therapy Type
7.1.3.1 Brazil T-Cell therapy Market by CAR T-Cell Therapy Type
7.2 Argentina T-Cell therapy Market
7.2.1 Argentina T-Cell therapy Market by End User
7.2.2 Argentina T-Cell therapy Market by Indication
7.2.3 Argentina T-Cell therapy Market by Therapy Type
7.2.3.1 Argentina T-Cell therapy Market by CAR T-Cell Therapy Type
7.3 UAE T-Cell therapy Market
7.3.1 UAE T-Cell therapy Market by End User
7.3.2 UAE T-Cell therapy Market by Indication
7.3.3 UAE T-Cell therapy Market by Therapy Type
7.3.3.1 UAE T-Cell therapy Market by CAR T-Cell Therapy Type
7.4 Saudi Arabia T-Cell therapy Market
7.4.1 Saudi Arabia T-Cell therapy Market by End User
7.4.2 Saudi Arabia T-Cell therapy Market by Indication
7.4.3 Saudi Arabia T-Cell therapy Market by Therapy Type
7.4.3.1 Saudi Arabia T-Cell therapy Market by CAR T-Cell Therapy Type
7.5 South Africa T-Cell therapy Market
7.5.1 South Africa T-Cell therapy Market by End User
7.5.2 South Africa T-Cell therapy Market by Indication
7.5.3 South Africa T-Cell therapy Market by Therapy Type
7.5.3.1 South Africa T-Cell therapy Market by CAR T-Cell Therapy Type
7.6 Nigeria T-Cell therapy Market
7.6.1 Nigeria T-Cell therapy Market by End User
7.6.2 Nigeria T-Cell therapy Market by Indication
7.6.3 Nigeria T-Cell therapy Market by Therapy Type
7.6.3.1 Nigeria T-Cell therapy Market by CAR T-Cell Therapy Type
7.7 Rest of LAMEA T-Cell therapy Market
7.7.1 Rest of LAMEA T-Cell therapy Market by End User
7.7.2 Rest of LAMEA T-Cell therapy Market by Indication
7.7.3 Rest of LAMEA T-Cell therapy Market by Therapy Type
7.7.3.1 Rest of LAMEA T-Cell therapy Market by CAR T-Cell Therapy Type
Chapter 8. Company Profiles
8.1 Merck KGaA
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 Johnson & Johnson
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.3 AbbVie, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Gilead Sciences, Inc.
8.4.1 Company overview
8.4.2 Financial Analysis
8.4.3 Research & Development Expenses
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.4.2 Acquisition and Mergers:
8.4.4.3 Trials and Approvals:
8.5 Amgen, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.6 Novartis AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Acquisition and Mergers:
8.6.5.3 Trials and Approvals:
8.7 Sorrento Therapeutics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.7.5.2 Trials and Approvals:
8.8 Bristol Myers Squibb Company
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.8.5.3 Geographical Expansions:
8.8.5.4 Trials and Approvals:
8.9 Pfizer, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional & Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Acquisition and Mergers:
8.10. Immunocore Holdings plc
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Research & Development Expenses
8.10.4 Recent strategies and developments:
8.10.4.1 Partnerships, Collaborations, and Agreements:
8.10.4.2 Trials and Approvals:



List of Figures

FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Sep – 2023, May) Leading Players
FIG 5 LAMEA T-Cell therapy Market share by End User, 2022
FIG 6 LAMEA T-Cell therapy Market share by End User, 2030
FIG 7 LAMEA T-Cell therapy Market by End User, 2019 - 2030, USD Million
FIG 8 LAMEA T-Cell therapy Market share by Indication, 2022
FIG 9 LAMEA T-Cell therapy Market share by Indication, 2030
FIG 10 LAMEA T-Cell therapy Market by Indication, 2019 - 2030, USD Million
FIG 11 LAMEA T-Cell therapy Market share by Therapy Type, 2022
FIG 12 LAMEA T-Cell therapy Market share by Therapy Type, 2030
FIG 13 LAMEA T-Cell therapy Market by Therapy Type, 2019 - 2030, USD Million
FIG 14 LAMEA T-Cell therapy Market share by Country, 2022
FIG 15 LAMEA T-Cell therapy Market share by Country, 2030
FIG 16 LAMEA T-Cell therapy Market by Country, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: Merck KGaA
FIG 18 Recent strategies and developments: Johnson & Johnson
FIG 19 SWOT analysis: Johnson & Johnson
FIG 20 Recent strategies and developments: Gilead Sciences, Inc.
FIG 21 Recent strategies and developments: Amgen, Inc.
FIG 22 Recent strategies and developments: Novartis AG
FIG 23 Recent strategies and developments: Sorrento Therapeutics, Inc.
FIG 24 Recent strategies and developments: Bristol Myers Squibb Company
FIG 25 Recent strategies and developments: Pfizer, Inc.
FIG 26 Recent strategies and developments: Immunocore Holdings plc

List of Tables

TABLE 1 LAMEA T-Cell therapy Market, 2019 - 2022, USD Million
TABLE 2 LAMEA T-Cell therapy Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– T-Cell therapy Market
TABLE 4 Product Launches And Product Expansions– T-Cell therapy Market
TABLE 5 Acquisition and Mergers– T-Cell therapy Market
TABLE 6 Geographical Expansions – T-Cell therapy Market
TABLE 7 Trials and Approvals – T-Cell therapy Market
TABLE 8 LAMEA T-Cell therapy Market by End User, 2019 - 2022, USD Million
TABLE 9 LAMEA T-Cell therapy Market by End User, 2023 - 2030, USD Million
TABLE 10 LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 11 LAMEA Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 12 LAMEA Cancer Treatment Centers Market by Country, 2019 - 2022, USD Million
TABLE 13 LAMEA Cancer Treatment Centers Market by Country, 2023 - 2030, USD Million
TABLE 14 LAMEA T-Cell therapy Market by Indication, 2019 - 2022, USD Million
TABLE 15 LAMEA T-Cell therapy Market by Indication, 2023 - 2030, USD Million
TABLE 16 LAMEA Lymphoma Market by Country, 2019 - 2022, USD Million
TABLE 17 LAMEA Lymphoma Market by Country, 2023 - 2030, USD Million
TABLE 18 LAMEA Acute Lymphocytic Leukemia Market by Country, 2019 - 2022, USD Million
TABLE 19 LAMEA Acute Lymphocytic Leukemia Market by Country, 2023 - 2030, USD Million
TABLE 20 LAMEA Others?Market by Country, 2019 - 2022, USD Million
TABLE 21 LAMEA Others?Market by Country, 2023 - 2030, USD Million
TABLE 22 LAMEA T-Cell therapy Market by Therapy Type, 2019 - 2022, USD Million
TABLE 23 LAMEA T-Cell therapy Market by Therapy Type, 2023 - 2030, USD Million
TABLE 24 LAMEA CAR T-Cell Therapy Market by Country, 2019 - 2022, USD Million
TABLE 25 LAMEA CAR T-Cell Therapy Market by Country, 2023 - 2030, USD Million
TABLE 26 LAMEA T-Cell therapy Market by CAR T-Cell Therapy Type, 2019 - 2022, USD Million
TABLE 27 LAMEA T-Cell therapy Market by CAR T-Cell Therapy Type, 2023 - 2030, USD Million
TABLE 28 LAMEA Axicabtagene Ciloleucel Market by Country, 2019 - 2022, USD Million
TABLE 29 LAMEA Axicabtagene Ciloleucel Market by Country, 2023 - 2030, USD Million
TABLE 30 LAMEA Tisagenlecleucel Market by Country, 2019 - 2022, USD Million
TABLE 31 LAMEA Tisagenlecleucel Market by Country, 2023 - 2030, USD Million
TABLE 32 LAMEA Brexucabtagene Autoleucel Market by Country, 2019 - 2022, USD Million
TABLE 33 LAMEA Brexucabtagene Autoleucel Market by Country, 2023 - 2030, USD Million
TABLE 34 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 35 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 36 LAMEA T-Cell Receptor (TCR)-Based Market by Country, 2019 - 2022, USD Million
TABLE 37 LAMEA T-Cell Receptor (TCR)-Based Market by Country, 2023 - 2030, USD Million
TABLE 38 LAMEA T-Cell therapy Market by Country, 2019 - 2022, USD Million
TABLE 39 LAMEA T-Cell therapy Market by Country, 2023 - 2030, USD Million
TABLE 40 Brazil T-Cell therapy Market, 2019 - 2022, USD Million
TABLE 41 Brazil T-Cell therapy Market, 2023 - 2030, USD Million
TABLE 42 Brazil T-Cell therapy Market by End User, 2019 - 2022, USD Million
TABLE 43 Brazil T-Cell therapy Market by End User, 2023 - 2030, USD Million
TABLE 44 Brazil T-Cell therapy Market by Indication, 2019 - 2022, USD Million
TABLE 45 Brazil T-Cell therapy Market by Indication, 2023 - 2030, USD Million
TABLE 46 Brazil T-Cell therapy Market by Therapy Type, 2019 - 2022, USD Million
TABLE 47 Brazil T-Cell therapy Market by Therapy Type, 2023 - 2030, USD Million
TABLE 48 Brazil T-Cell therapy Market by CAR T-Cell Therapy Type, 2019 - 2022, USD Million
TABLE 49 Brazil T-Cell therapy Market by CAR T-Cell Therapy Type, 2023 - 2030, USD Million
TABLE 50 Argentina T-Cell therapy Market, 2019 - 2022, USD Million
TABLE 51 Argentina T-Cell therapy Market, 2023 - 2030, USD Million
TABLE 52 Argentina T-Cell therapy Market by End User, 2019 - 2022, USD Million
TABLE 53 Argentina T-Cell therapy Market by End User, 2023 - 2030, USD Million
TABLE 54 Argentina T-Cell therapy Market by Indication, 2019 - 2022, USD Million
TABLE 55 Argentina T-Cell therapy Market by Indication, 2023 - 2030, USD Million
TABLE 56 Argentina T-Cell therapy Market by Therapy Type, 2019 - 2022, USD Million
TABLE 57 Argentina T-Cell therapy Market by Therapy Type, 2023 - 2030, USD Million
TABLE 58 Argentina T-Cell therapy Market by CAR T-Cell Therapy Type, 2019 - 2022, USD Million
TABLE 59 Argentina T-Cell therapy Market by CAR T-Cell Therapy Type, 2023 - 2030, USD Million
TABLE 60 UAE T-Cell therapy Market, 2019 - 2022, USD Million
TABLE 61 UAE T-Cell therapy Market, 2023 - 2030, USD Million
TABLE 62 UAE T-Cell therapy Market by End User, 2019 - 2022, USD Million
TABLE 63 UAE T-Cell therapy Market by End User, 2023 - 2030, USD Million
TABLE 64 UAE T-Cell therapy Market by Indication, 2019 - 2022, USD Million
TABLE 65 UAE T-Cell therapy Market by Indication, 2023 - 2030, USD Million
TABLE 66 UAE T-Cell therapy Market by Therapy Type, 2019 - 2022, USD Million
TABLE 67 UAE T-Cell therapy Market by Therapy Type, 2023 - 2030, USD Million
TABLE 68 UAE T-Cell therapy Market by CAR T-Cell Therapy Type, 2019 - 2022, USD Million
TABLE 69 UAE T-Cell therapy Market by CAR T-Cell Therapy Type, 2023 - 2030, USD Million
TABLE 70 Saudi Arabia T-Cell therapy Market, 2019 - 2022, USD Million
TABLE 71 Saudi Arabia T-Cell therapy Market, 2023 - 2030, USD Million
TABLE 72 Saudi Arabia T-Cell therapy Market by End User, 2019 - 2022, USD Million
TABLE 73 Saudi Arabia T-Cell therapy Market by End User, 2023 - 2030, USD Million
TABLE 74 Saudi Arabia T-Cell therapy Market by Indication, 2019 - 2022, USD Million
TABLE 75 Saudi Arabia T-Cell therapy Market by Indication, 2023 - 2030, USD Million
TABLE 76 Saudi Arabia T-Cell therapy Market by Therapy Type, 2019 - 2022, USD Million
TABLE 77 Saudi Arabia T-Cell therapy Market by Therapy Type, 2023 - 2030, USD Million
TABLE 78 Saudi Arabia T-Cell therapy Market by CAR T-Cell Therapy Type, 2019 - 2022, USD Million
TABLE 79 Saudi Arabia T-Cell therapy Market by CAR T-Cell Therapy Type, 2023 - 2030, USD Million
TABLE 80 South Africa T-Cell therapy Market, 2019 - 2022, USD Million
TABLE 81 South Africa T-Cell therapy Market, 2023 - 2030, USD Million
TABLE 82 South Africa T-Cell therapy Market by End User, 2019 - 2022, USD Million
TABLE 83 South Africa T-Cell therapy Market by End User, 2023 - 2030, USD Million
TABLE 84 South Africa T-Cell therapy Market by Indication, 2019 - 2022, USD Million
TABLE 85 South Africa T-Cell therapy Market by Indication, 2023 - 2030, USD Million
TABLE 86 South Africa T-Cell therapy Market by Therapy Type, 2019 - 2022, USD Million
TABLE 87 South Africa T-Cell therapy Market by Therapy Type, 2023 - 2030, USD Million
TABLE 88 South Africa T-Cell therapy Market by CAR T-Cell Therapy Type, 2019 - 2022, USD Million
TABLE 89 South Africa T-Cell therapy Market by CAR T-Cell Therapy Type, 2023 - 2030, USD Million
TABLE 90 Nigeria T-Cell therapy Market, 2019 - 2022, USD Million
TABLE 91 Nigeria T-Cell therapy Market, 2023 - 2030, USD Million
TABLE 92 Nigeria T-Cell therapy Market by End User, 2019 - 2022, USD Million
TABLE 93 Nigeria T-Cell therapy Market by End User, 2023 - 2030, USD Million
TABLE 94 Nigeria T-Cell therapy Market by Indication, 2019 - 2022, USD Million
TABLE 95 Nigeria T-Cell therapy Market by Indication, 2023 - 2030, USD Million
TABLE 96 Nigeria T-Cell therapy Market by Therapy Type, 2019 - 2022, USD Million
TABLE 97 Nigeria T-Cell therapy Market by Therapy Type, 2023 - 2030, USD Million
TABLE 98 Nigeria T-Cell therapy Market by CAR T-Cell Therapy Type, 2019 - 2022, USD Million
TABLE 99 Nigeria T-Cell therapy Market by CAR T-Cell Therapy Type, 2023 - 2030, USD Million
TABLE 100 Rest of LAMEA T-Cell therapy Market, 2019 - 2022, USD Million
TABLE 101 Rest of LAMEA T-Cell therapy Market, 2023 - 2030, USD Million
TABLE 102 Rest of LAMEA T-Cell therapy Market by End User, 2019 - 2022, USD Million
TABLE 103 Rest of LAMEA T-Cell therapy Market by End User, 2023 - 2030, USD Million
TABLE 104 Rest of LAMEA T-Cell therapy Market by Indication, 2019 - 2022, USD Million
TABLE 105 Rest of LAMEA T-Cell therapy Market by Indication, 2023 - 2030, USD Million
TABLE 106 Rest of LAMEA T-Cell therapy Market by Therapy Type, 2019 - 2022, USD Million
TABLE 107 Rest of LAMEA T-Cell therapy Market by Therapy Type, 2023 - 2030, USD Million
TABLE 108 Rest of LAMEA T-Cell therapy Market by CAR T-Cell Therapy Type, 2019 - 2022, USD Million
TABLE 109 Rest of LAMEA T-Cell therapy Market by CAR T-Cell Therapy Type, 2023 - 2030, USD Million
TABLE 110 key Information – Merck KGaA
TABLE 111 Key information –Johnson & Johnson
TABLE 112 Key information – AbbVie, Inc.
TABLE 113 Key Information – Gilead Sciences, Inc.
TABLE 114 Key Information – Amgen, Inc.
TABLE 115 Key Information – Novartis AG
TABLE 116 Key Information – Sorrento Therapeutics, Inc.
TABLE 117 Key Information – Bristol Myers Squibb Company
TABLE 118 Key Information – Pfizer, Inc.
TABLE 119 Key Information – Immunocore Holdings plc